Nurix Therapeutics Statistics
Total Valuation
NRIX has a market cap or net worth of $983.19 million. The enterprise value is $767.45 million.
Market Cap | 983.19M |
Enterprise Value | 767.45M |
Important Dates
The next estimated earnings date is Thursday, July 11, 2024, after market close.
Earnings Date | Jul 11, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
NRIX has 59.32 million shares outstanding. The number of shares has increased by 1.62% in one year.
Shares Outstanding | 59.32M |
Shares Change (YoY) | +1.62% |
Shares Change (QoQ) | +0.43% |
Owned by Insiders (%) | 2.18% |
Owned by Institutions (%) | 85.81% |
Float | 38.65M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 12.16 |
Forward PS | 12.72 |
PB Ratio | 5.83 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 9.49 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.86, with a Debt / Equity ratio of 0.17.
Current Ratio | 2.86 |
Quick Ratio | n/a |
Debt / Equity | 0.17 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -67.10% and return on invested capital (ROIC) is -79.50%.
Return on Equity (ROE) | -67.10% |
Return on Assets (ROA) | -43.60% |
Return on Capital (ROIC) | -79.50% |
Revenue Per Employee | $284,813 |
Profits Per Employee | -$509,623 |
Employee Count | 284 |
Asset Turnover | 0.24 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, NRIX has paid $90,000 in taxes.
Income Tax | 90,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +65.73% in the last 52 weeks. The beta is 2.10, so NRIX's price volatility has been higher than the market average.
Beta (1Y) | 2.10 |
52-Week Price Change | +65.73% |
50-Day Moving Average | 14.12 |
200-Day Moving Average | 9.74 |
Relative Strength Index (RSI) | 64.97 |
Average Volume (30 Days) | 1,083,003 |
Short Selling Information
The latest short interest is 6.90 million, so 11.64% of the outstanding shares have been sold short.
Short Interest | 6.90M |
Short Previous Month | 7.04M |
Short % of Shares Out | 11.64% |
Short % of Float | 17.87% |
Short Ratio (days to cover) | 5.21 |
Income Statement
In the last 12 months, NRIX had revenue of $80.89 million and -$144.73 million in losses. Loss per share was -$2.66.
Revenue | 80.89M |
Gross Profit | 80.89M |
Operating Income | -157.33M |
Pretax Income | -144.64M |
Net Income | -144.73M |
EBITDA | -130.28M |
EBIT | -144.64M |
Loss Per Share | -$2.66 |
Balance Sheet
The company has $244.89 million in cash and $29.16 million in debt, giving a net cash position of $215.74 million or $3.64 per share.
Cash & Cash Equivalents | 244.89M |
Total Debt | 29.16M |
Net Cash | 215.74M |
Net Cash Per Share | $3.64 |
Equity / Book Value | 168.75M |
Book Value Per Share | 2.84 |
Working Capital | 163.35M |
Cash Flow
In the last 12 months, operating cash flow was -$74.86 million and capital expenditures -$9.01 million, giving a free cash flow of -$83.87 million.
Operating Cash Flow | -74.86M |
Capital Expenditures | -9.01M |
Free Cash Flow | -83.87M |
FCF Per Share | -$1.53 |
Margins
Gross margin is 100.00%, with operating and profit margins of -194.51% and -178.93%.
Gross Margin | 100.00% |
Operating Margin | -194.51% |
Pretax Margin | -178.82% |
Profit Margin | -178.93% |
EBITDA Margin | -161.07% |
EBIT Margin | -178.82% |
FCF Margin | -103.69% |
Dividends & Yields
NRIX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.62% |
Shareholder Yield | -1.62% |
Earnings Yield | -14.72% |
FCF Yield | -8.53% |
Analyst Forecast
The average price target for NRIX is $22.22, which is 33.94% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $22.22 |
Price Target Difference | 33.94% |
Analyst Consensus | Strong Buy |
Analyst Count | 9 |
Revenue Growth Forecast (5Y) | 31.17% |
EPS Growth Forecast (5Y) | -10.43% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
NRIX has an Altman Z-Score of 0.83 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 0.83 |
Piotroski F-Score | 2 |